- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06204211
Genetic Research on High Myopic Individuals in Northern China
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
As a serious pattern of myopia, high myopia (HM) generally refers to a condition where the spherical equivalent (SE) refraction exceeds -6.00 diopters (D) or the axial length (AL) is longer than 26.00 mm. Abundant studies have indicated the strong correlation of HM with multiple vision-threatening ophthalmic diseases, including rhegmatogenous retinal detachment, retinoschisis, retinochoroid atrophy and open-angle glaucoma. It is reported that the worldwide prevalence of HM has surpassed over 2.9% in recent years. And a study on subjects living in Minnesota from the 1960s to the 2010s demonstrates that the data has progressively increasing from 2.8% to 8.3%, which is not related with gender or race, although no evident significance has yet been proved in some groups. What's worse, it is speculated that HM patients are expected to account for 9.8% of the global population by 2050, which will gravely hinder the progress of social development. As a result, it is of profound implications to explore the pathogenesis of HM and the prospective therapeutic or remedial strategies.
What has been universally acknowledged is that both environmental and genetic factors matter much in the onset and exacerbation of myopia, with the latter particularly predominating in the etiology of HM. Accordingly, discussing the causation of HM from heredity version is likely to be the most promising research field, which is just the researchers' interest at the present.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Henan
-
Zhengzhou, Henan, China, 450052
- Liping Du
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- HM participants are characterized by AL ≥ 26.00 mm or SE ≤ -6.00 D in at least one eye.
Exclusion Criteria:
- Individuals with other ocular or systemic connective tissue diseases were excluded.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
High myopia
HM participants characterized by AL ≥ 26.00 mm or SE ≤ -6.00 D in at least one eye at the Department of Ophthalmology of the First Affiliated Hospital of Zhengzhou University (Zhengzhou, Henan Province, China) from May 2022 to April 2023 are included as cases.
|
All the included personnel underwent routine ophthalmologic examinations on binoculus, including slit lamp microscope observation, intraocular pressure, diopters of refractive error, best corrected visual acuity, AL measurement, fundus photography and optical coherence tomography, adhering to the established and normalized principles.
|
|
Control
Demographic-matched emmetropic volunteers without consanguinity serve as controls.
|
All the included personnel underwent routine ophthalmologic examinations on binoculus, including slit lamp microscope observation, intraocular pressure, diopters of refractive error, best corrected visual acuity, AL measurement, fundus photography and optical coherence tomography, adhering to the established and normalized principles.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
diopter
Time Frame: 1 hour
|
This study performs the subgroup analysis based on SE (≤ -20.00 D, -20.00 ~ -15.00 D, -15.00 ~ -10.00 D, and -10.00 ~ -6.00 D) to clarify the correlation between different genetic SNPs and HM inclination more thoroughly.
|
1 hour
|
Collaborators and Investigators
Investigators
- Study Chair: Liping Du, The First Affiliated Hospital of Zhengzhou University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-KY-0512-002
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on High Myopia
-
Shanghai Eye Disease Prevention and Treatment CenterShanghai General Hospital, Shanghai Jiao Tong University School of MedicineEnrolling by invitationHigh Myopia | Pathologic MyopiaChina
-
Fuzhou Eye HospitalAlcon ResearchNot yet recruiting
-
Shanghai Eye Disease Prevention and Treatment CenterNot yet recruiting
-
The Hong Kong Polytechnic UniversityAston University; Queensland University of TechnologyRecruiting
-
Sun Yat-sen UniversitySuspended
-
Shanghai Eye Disease Prevention and Treatment CenterEssilor InternationalNot yet recruiting
-
Shanghai Eye Disease Prevention and Treatment CenterShanghai General Hospital, Shanghai Jiao Tong University School of Medicine; Shandong University of Traditional Chinese MedicineNot yet recruiting
-
Tianjin Eye HospitalActive, not recruitingMyopia | High MyopiaChina
Clinical Trials on ophthalmologic examinations
-
Holostem Terapie Avanzate s.r.l.CromsourceCompletedLimbal Stem Cell Deficiency Due to Ocular BurnItaly
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis FoundationCompletedCystic FibrosisUnited States
-
Centre Hospitalier St AnneCompletedPatients With Cognitive DisturbancesFrance
-
Fondation Ophtalmologique Adolphe de RothschildCompletedCovid19 | Sars-CoV2France
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruiting
-
University Hospital, ToulouseNot yet recruitingAttention Deficit Disorder With Hyperactivity
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
Burapha UniversityCompletedAtrial Fibrillation | Type 2 DiabetesThailand
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
Yuanjun YangActive, not recruitingEnd-Stage Renal Disease Requiring HaemodialysisChina